Anti-CX(3)CR1 antibody treatment prolongs murine cardiac allograft survival.
Publication
, Conference
Robinson, LA; Nataraj, C; Griffiths, R; Howell, DN; Patel, DD; Feng, LL; Coffman, TM
Published in: TRANSPLANTATION
April 27, 2000
Duke Scholars
Published In
TRANSPLANTATION
ISSN
0041-1337
Publication Date
April 27, 2000
Volume
69
Issue
8
Start / End Page
S125 / S125
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Robinson, L. A., Nataraj, C., Griffiths, R., Howell, D. N., Patel, D. D., Feng, L. L., & Coffman, T. M. (2000). Anti-CX(3)CR1 antibody treatment prolongs murine cardiac allograft survival. In TRANSPLANTATION (Vol. 69, pp. S125–S125). LIPPINCOTT WILLIAMS & WILKINS.
Robinson, L. A., C. Nataraj, R. Griffiths, D. N. Howell, D. D. Patel, L. L. Feng, and T. M. Coffman. “Anti-CX(3)CR1 antibody treatment prolongs murine cardiac allograft survival.” In TRANSPLANTATION, 69:S125–S125. LIPPINCOTT WILLIAMS & WILKINS, 2000.
Robinson LA, Nataraj C, Griffiths R, Howell DN, Patel DD, Feng LL, et al. Anti-CX(3)CR1 antibody treatment prolongs murine cardiac allograft survival. In: TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. S125–S125.
Robinson, L. A., et al. “Anti-CX(3)CR1 antibody treatment prolongs murine cardiac allograft survival.” TRANSPLANTATION, vol. 69, no. 8, LIPPINCOTT WILLIAMS & WILKINS, 2000, pp. S125–S125.
Robinson LA, Nataraj C, Griffiths R, Howell DN, Patel DD, Feng LL, Coffman TM. Anti-CX(3)CR1 antibody treatment prolongs murine cardiac allograft survival. TRANSPLANTATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. S125–S125.
Published In
TRANSPLANTATION
ISSN
0041-1337
Publication Date
April 27, 2000
Volume
69
Issue
8
Start / End Page
S125 / S125
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
- 11 Medical and Health Sciences